ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,282.70
0.13%
US Tech 100
17,825.60
0.33%
Dow Jones
39,142.23
-1.33%
Brent Oil
67.075
0.00%
Bitcoin
84,484.40
0.00%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Protagenic Therapeutics Inc (PTIX) Quote

Protagenic Therapeutics Inc

Protagenic Therapeutics Inc (PTIX)

NASDAQ
0.2399
-0.0171
(-6.65%)
Closed April 18 4:00PM
Delayed by 15 minutes
0.23
-0.0099
(-4.13%)
After Hours: 7:23PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.23
Bid
0.226
Ask
0.23
Volume
216,615
0.2259 Day's Range 0.257
0.179 52 Week Range 1.87
Market Cap
1.731M
Previous Close
0.257
Open
0.2517
Last Trade
125
@
0.23
(formt)
Last Trade Time
Financial Volume
$ 53,051
VWAP
0.244908
Average Volume (3m)
5,683,011
Shares Outstanding
7,525,681
Dividend Yield
-
PE Ratio
-0.35
Earnings Per Share (EPS)
-0.66
Revenue
-
Net Profit
-5M

About Protagenic Therapeutics Inc

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more

Sector
Business Services, Nec
Industry
Books: Pubg, Pubg & Printing
Website
www.protagenic.com
Headquarters
Wilmington, Delaware, USA
Founded
2007
Protagenic Therapeutics Inc is listed in the Business Services sector of the NASDAQ with ticker PTIX. The last closing price for Protagenic Therapeutics was $0.26. Over the last year, Protagenic Therapeutics shares have traded in a share price range of $ 0.179 to $ 1.87.

Protagenic Therapeutics currently has 7,525,681 shares outstanding. The market capitalization of Protagenic Therapeutics is $1.93 million. Protagenic Therapeutics has a price to earnings ratio (PE ratio) of -0.35.

Ask ADVFN Intelligence (AI)

PTIX Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
August 14 2024
PTIX (-6.65%)

Form 8-K - Current report
Edgar (US Regulatory)
July 26 2024
PTIX (-6.65%)

Form 8-K - Current report
Edgar (US Regulatory)
December 15 2023
PTIX (-6.65%)

Form 8-K - Current report
Edgar (US Regulatory)
November 29 2023
PTIX (-6.65%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 14 2023
PTIX (-6.65%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
November 02 2023
PTIX (-6.65%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
October 13 2023
PTIX (-6.65%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
August 14 2023
PTIX (-6.65%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.029-11.19691119690.2590.310.2262076360.288677CS
4-0.02-80.250.5990.179103481610.39743816CS
12-0.204-47.00460829490.4340.61960.17956830110.38314606CS
26-0.34-59.6491228070.571.090.17928012970.39573463CS
52-1.17-83.57142857141.41.870.17914523200.41729575CS
156-3.13-93.15476190483.363.660.1794937540.46108455CS
260-14.73-98.462566844914.9619.560.1796140655.63190032CS

PTIX - Frequently Asked Questions (FAQ)

What is the current Protagenic Therapeutics share price?
The current share price of Protagenic Therapeutics is $ 0.23
How many Protagenic Therapeutics shares are in issue?
Protagenic Therapeutics has 7,525,681 shares in issue
What is the market cap of Protagenic Therapeutics?
The market capitalisation of Protagenic Therapeutics is USD 1.93M
What is the 1 year trading range for Protagenic Therapeutics share price?
Protagenic Therapeutics has traded in the range of $ 0.179 to $ 1.87 during the past year
What is the PE ratio of Protagenic Therapeutics?
The price to earnings ratio of Protagenic Therapeutics is -0.35
What is the reporting currency for Protagenic Therapeutics?
Protagenic Therapeutics reports financial results in USD
What is the latest annual profit for Protagenic Therapeutics?
The latest annual profit of Protagenic Therapeutics is USD -5M
What is the registered address of Protagenic Therapeutics?
The registered address for Protagenic Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagenic Therapeutics website address?
The website address for Protagenic Therapeutics is www.protagenic.com
Which industry sector does Protagenic Therapeutics operate in?
Protagenic Therapeutics operates in the BOOKS: PUBG, PUBG & PRINTING sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
$ 8.205
(43.70%)
266.91M

PTIX Discussion

View Posts
glenn1919 glenn1919 2 weeks ago
PTIX............................................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
👍️0
boston127 boston127 2 weeks ago
PTIX appears to be consolidating

within a longer term downtrend. Shares are presently below the 200-day moving average, which is falling along with the 10-day moving average. However, the Average Directional Index, or ADX, is below 20, indicating that shares have exhibited sideways movement recently. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500.
👍️0
glenn1919 glenn1919 2 weeks ago
PTIX..................................................p/m
👍️0
glenn1919 glenn1919 2 weeks ago
PTIX............................................weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
👍️0
tw0122 tw0122 2 weeks ago
.60s low float beatdown pharmas performing well plenty of 300 to 600% percenters 
👍️0
tw0122 tw0122 2 weeks ago
Back to .50s
👍️0
glenn1919 glenn1919 2 weeks ago
PTIX...........................................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 months ago
Maybe not quite to the moon but .50 + 62%
👍️0
Invest-in-America Invest-in-America 5 months ago
PTIX: To dah MOOOOOOOON!! (Join the FUN!!)
👍️0
Invest-in-America Invest-in-America 5 months ago
PTIX: To dah MOOOOOOOON!! (Join the FUN!!)
👍️0
Jimmy Santos Jimmy Santos 5 months ago
When are the earnings coming out ???? Due any day now?
👍️0
glenn1919 glenn1919 7 months ago
PTIX......................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
PTIX 10Q due 4/1 per Seeking Alpha
👍️0
Monksdream Monksdream 1 year ago
PTIX under $2
👍️0
glenn1919 glenn1919 1 year ago
PTIX............................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
👍️0
Triple nickle Triple nickle 1 year ago
It’s getting there
👍️0
Monksdream Monksdream 1 year ago
PTIX new 52 week low
👍️0
willlbone willlbone 2 years ago
Buy the dip, Back to $1.40 in a month.
👍️0
willlbone willlbone 2 years ago
Looks like insiders got some news. Dollar will fall.
👍️0
Monksdream Monksdream 2 years ago
PTIX under $2
👍️0
jalive jalive 3 years ago
Do you think this company is going to start trails in February?
👍️0
jalive jalive 3 years ago
Whats the deal with this company now anyone know?
👍️0
jalive jalive 3 years ago
Hey, I read through most of your post on the board here. Any ideas where this company stands today? Came across my radar and it seems they are still in IND phase. Interested to hear what you think, thanks in advance!
👍️0
smoke_em smoke_em 4 years ago
https://reactiongifs.me/wp-content/uploads/2013/08/breaking-bad-money-bed.gif
👍️0
CYDYWinning CYDYWinning 4 years ago
Hey clay is here! This is when you know it’s a pump and dump. Stay away.
👍️0
lukin4winners lukin4winners 4 years ago
PTIX hits $4.06 pre market short squeeze. More to come.
👍️0
ClayTrader ClayTrader 4 years ago
* * $PTIX Video Chart 05-10-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Roadtojourney Roadtojourney 4 years ago
New bagholder here lol imo
👍️0
cjstocksup cjstocksup 4 years ago
Buying the dips there awhile ago paid off nicely. Loved the swings today.
👍️0
aristotelisonassis aristotelisonassis 4 years ago
Beast mode today!
👍️0
KeepOn KeepOn 4 years ago
Maybe now?
👍️0
KeepOn KeepOn 4 years ago
Maybe now?
👍️0
trader59 trader59 4 years ago
Not a good look for the underwriter. Sold units of stock plus warrant priced at $4.15 (warrant at 120% of that), stock price plunges 50% on NASDAQ. Pretty sure their customers aren't happy.
👍️0
honest dave honest dave 4 years ago
Been watching all day for bottom. I think we're there.
👍️0
Renee Renee 4 years ago
PTIX moved to the Nasdaq from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions
👍️0
kkpennies kkpennies 5 years ago
There is a vote today:

To ratify the appointment of MaloneBailey, LLP as our independent registered public accounting firm for the year ending December 31, 2020.
👍️0
jimmyburkitt jimmyburkitt 5 years ago
LMAO. GO ATRN!!!

👍️0
Soffi Soffi 6 years ago
Many thanks, I think this is also a reputable ringtone site you should know https://toqueparacelular.net/
👍️0
Soffi Soffi 6 years ago
Many thanks, I think this is also a reputable ringtone site you should know https://toqueparacelular.net/
👍️0
Q7 Q7 6 years ago
..is ABBA even still around? #ATRAIN4EVER lol
👍️0
eddy2 eddy2 7 years ago
Keep hanging in there guys. You may want to tell your neighbors to buy as well.
👍️0
eddy2 eddy2 7 years ago
https://www.stepchange.org/debt-info/debt-collection/can-debts-be-sold-on.aspx

If a companies piggy backed credit falls into the rears they the corporation that is piggy backed can sell there debt. This piggy backed credit will show up as a loss and partial tax gain.

The collateral is the credit pre taxed. If the credit is sold at a loss it shows up in the financials as a sharehlolders deficit. The money paid for the credit showes up as a tax credit for the money lost as well the tax on the credit sold as a net revenue.

If the debt holder had paid the creditors then only money on profit is taxed.

So selling the credit to a third party automatically sets up a tax credit for the full amount offered by the third party purchaser of the credit.

You cannot defer the tax’s as in the case of a direct payment from the debtor.

The reason for this is that there must be a way to separate the third party expenses.

Banks do this all time. It’s called accurred accounting. Accounting that shows all relative losses as they are presented.

Do your own DD. Don’t take anyone’s word not even ours.
👍️0
eddy2 eddy2 7 years ago
If everyone felt that way then your assumption is correct. The company is selling equity at far less to raise capital too cover there debt slowly diluting the five dollar interest you mentioned. It’s what comes out of the capital raised that is important boasting the retained earnings from the selling of the debt.
👍️0
eddy2 eddy2 7 years ago
So Sly because of this private placement we the early investors are not fully engaged in the collateral offering. I can only assume then there are others. This of course has let us participate in trading only a small portion of our interest. Will we be included in the second offering to hold an annuity position larger then the one we hold now?

I wouldn’t part with my interest for less then $5 a share. How do you feel about that?
👍️0
eddy2 eddy2 7 years ago
Private placements of collateral for debt are very complex and are often if not always paid through equity dilution.

When paid in capital through retained earnings ie: the issuing of equity paper too the ones who put up the collateral for the debt by the means of restricted shares known as outstanding shares then trade there debt with the banks debt and the bank then sells the collateral or debt too new investors.

The investors who last bought the issued revolving debt then become the new collateral holders.

The question then arises what of the interest of the previous collateral holders. They in fact become unsecured creditors to the company ie: holders of treasury stock.

If there is no treasury then there interest has been abolished or removed. Held in trust by the government as a part of the tax debt owed to be paid by depreciated assets if and only if those costs can be forwarded to the customer or client of the service offered ie: retained earnings for the sale of equity above the capital cost of the equities par value.

You scratch his back the next group will scratch yours.

👍️0
eddy2 eddy2 7 years ago
Private placement will be carried out shortly. The way this often works is collateral will be put up for debt too sell equity. The person putting up the equity ie: placement for collateral. The money raised will be used too return capital to the debt holders. The ones who put up the collateral will be paid an administration fee for the use of the collateral and will share that gain with the new stake holders.
👍️0
eddy2 eddy2 7 years ago
https://www.thebalance.com/what-is-an-alienation-clause-1798510

Make sure you understand all the finer details of the contract to lease.
👍️0
eddy2 eddy2 7 years ago
Mmmmm, so you say.
👍️0
eddy2 eddy2 7 years ago
There always set up as a lease to purchase. Meaning the equity is leased and the shares purchased back from the proceeds of the lease for the original stakeholders. Any new capital raised goes toward the equity purchase.

There is tax’s for the sale and purchase as well the generated revenue from leasing the interest. Any capital depreciation on the assets leased are reimbursed back to both parties involved. One as a notable tax savings or credit that will go toward the purchase off setting the companies tax’s owed ie: treasury minus shareholders deficit.

The lease costs take into account the recievables and payables. Liability is made up of all debt including the lease payments required. If the lease contract to purchase expires as stated in the perspective and articles of incorporation and is not renewed or fully fulfilled then proceeds will be returned minus any depreciated asset costs, and tax’s owed plus any shareholders deficit “ capital borrowed too full fill the lease obligations”.
👍️0
eddy2 eddy2 7 years ago
https://dunerats.bandcamp.com/track/bullshit
👍️0

Your Recent History

NASDAQ
PTIX
Protagenic Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads